Catawba Research, LLC
Charlotte, North Carolina 28217
0 studies enrolling now · 12 studies all time
What they study most
Acne Vulgaris, Plaque Psoriasis, Rosacea, Scalp Psoriasis, Tinea Pedis
Studies at this site
- Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris — Completed
- An Open-Label Study to Assess Safety — Completed
- A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis. — Completed
- A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis. — Completed
- A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris — Completed
- A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris — Completed
- A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris — Completed
- Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris — Completed
- To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea — Completed
- To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis — Completed
- To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris — Completed
- To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris — Completed